Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-guided Ethanol Injection for Pancreatic Cysts
NCT02158039Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2004
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ethanol in Pancreatic cystic neoplasm, sponsored by Mayo Clinic. Primary endpoints: Number of Participants With Adverse Events as a Measure of Safety and Tolerability at 1 year and Number of Subjects With Complete or Partial Ablation of the Treated Cyst at 1 year. Started Jun 2004; status: completed.
02
Drugs
ethanol
03
Conditions
Pancreatic cystic neoplasm
Beyond the preview
Go deeper on NCT02158039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158039.